IOVA Q2 2021 Earnings — Iovance Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena

IOVAIovance Biotherapeutics, Inc.

$2B

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$81M

Net Income

-$81M

EPS (Diluted)

$-0.53

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$54M

Free Cash Flow

-$64M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$853M

Total Liabilities

$108M

Stockholders' Equity

$744M

Cash & Equivalents

$83M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$81M	-$64M	-28.0%
Net Income	-$81M	-$63M	-29.1%